Similar to previous findings, the survival for glioblastoma was significantly worse than for astrocytoma, WHO grade 4, which is supporting evidence to distinguish IDH-mutant astrocytoma from IDH-wildtype glioblastoma (17). This evidence concerns the gene IDH1 and glioblastoma.